Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
Details for Australian Patent Application No. 2003249882 (hide)
International Classifications
Event Publications
16 October 2003 Complete Application Filed
Priority application(s): 60/391,246 26.06.02 US; 03 004 744.3 04.03.03 EP; 02 018 724.1 21.08.02 EP; 60/391,245 26.06.02 US; 60/391,244 26.06.02 US; 02 018 907.2 23.08.02 EP
4 March 2004 Application Open to Public Inspection
Published as AU-B-2003249882
28 April 2005 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 28 Jan 2005
5 October 2006 Assignment before Grant
MediGene Oncology GmbH The application has been assigned to MediGene AG
18 September 2008 Application Accepted
Published as AU-B-2003249882
22 January 2009 Standard Patent Sealed
27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003249883-SECRETED POLYPEPTIDE SPECIES ASSOCIATED WITH CARDIOVASCULAR DISORDERS
2003249881-DIARYLMETHYLPIPERAZINES AS PROPHYLACTIC OR THERAPEUTIC AGENTS FOR VIRAL MYOCARDITIS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser